Differentiation alters the unstable expression of adenine phosphoribosyltransferase in mouse teratocarcinoma cells. 1986

M S Turker, and J A Tischfield, and P Rabinovitch, and P J Stambrook, and J J Trill, and A C Smith, and C E Ogburn, and G M Martin

Three multipotent mouse teratocarcinoma stem lines, all exhibiting unstable expression for the purine salvage enzyme adenine phosphoribosyltransferase (APRT) were used for the isolation of differentiated cell lines from neoplasms developed in syngeneic mice. Two of the stem cell lines (DAP1B and DAP1C) exhibited homozygous deficiencies for APRT expression while the third stem cell line (E140) exhibited a heterozygous deficiency (Turker, M.S., Smith, A.C., and Martin, G.M.; Somat. Cell Mol. Genet.; 10:55-69; 1984). A total of 16 morphologically differentiated cell lines were established from these neoplasms; most were no longer tumorigenic. Differentiated cell lines derived from the E140-induced tumors segregated homozygous deficient mutants in a single step, consistent with their retention of the heterozygous deficient state. Differentiated homozygous deficient cell lines gave rise to phenotypic revertants at very high frequencies (10(-1) to 10(-2)). The majority of these putative revertants, however, yielded cell-free extracts with little or no detectable APRT activity. These putative revertants were capable of adenine salvage and were therefore termed APRT pseudorevertants. Since the APRT pseudorevertant phenotype was only observed in the differentiated progeny of the APRT deficient stem cell lines, we conclude that this change in the nature of the revertant phenotype was a consequence of cellular differentiation.

UI MeSH Term Description Entries
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D010430 Pentosyltransferases Enzymes of the transferase class that catalyze the transfer of a pentose group from one compound to another.
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000228 Adenine Phosphoribosyltransferase An enzyme catalyzing the formation of AMP from adenine and phosphoribosylpyrophosphate. It can act as a salvage enzyme for recycling of adenine into nucleic acids. EC 2.4.2.7. AMP Pyrophosphorylase,Transphosphoribosidase,APRTase,Phosphoribosyltransferase, Adenine,Pyrophosphorylase, AMP
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013724 Teratoma A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642) Dysembryoma,Teratoid Tumor,Teratoma, Cystic,Teratoma, Mature,Teratoma, Benign,Teratoma, Immature,Teratoma, Malignant,Benign Teratoma,Benign Teratomas,Dysembryomas,Immature Teratoma,Immature Teratomas,Malignant Teratoma,Malignant Teratomas,Teratoid Tumors,Teratomas,Teratomas, Benign,Teratomas, Immature,Teratomas, Malignant,Tumor, Teratoid,Tumors, Teratoid

Related Publications

M S Turker, and J A Tischfield, and P Rabinovitch, and P J Stambrook, and J J Trill, and A C Smith, and C E Ogburn, and G M Martin
January 1984, Somatic cell and molecular genetics,
M S Turker, and J A Tischfield, and P Rabinovitch, and P J Stambrook, and J J Trill, and A C Smith, and C E Ogburn, and G M Martin
November 1979, Somatic cell genetics,
M S Turker, and J A Tischfield, and P Rabinovitch, and P J Stambrook, and J J Trill, and A C Smith, and C E Ogburn, and G M Martin
December 1985, Experimental parasitology,
M S Turker, and J A Tischfield, and P Rabinovitch, and P J Stambrook, and J J Trill, and A C Smith, and C E Ogburn, and G M Martin
January 1983, Gene,
M S Turker, and J A Tischfield, and P Rabinovitch, and P J Stambrook, and J J Trill, and A C Smith, and C E Ogburn, and G M Martin
January 1982, Differentiation; research in biological diversity,
M S Turker, and J A Tischfield, and P Rabinovitch, and P J Stambrook, and J J Trill, and A C Smith, and C E Ogburn, and G M Martin
July 1990, Somatic cell and molecular genetics,
M S Turker, and J A Tischfield, and P Rabinovitch, and P J Stambrook, and J J Trill, and A C Smith, and C E Ogburn, and G M Martin
June 1982, Proceedings of the National Academy of Sciences of the United States of America,
M S Turker, and J A Tischfield, and P Rabinovitch, and P J Stambrook, and J J Trill, and A C Smith, and C E Ogburn, and G M Martin
February 1993, Cancer letters,
M S Turker, and J A Tischfield, and P Rabinovitch, and P J Stambrook, and J J Trill, and A C Smith, and C E Ogburn, and G M Martin
March 1982, Molecular and cellular biology,
M S Turker, and J A Tischfield, and P Rabinovitch, and P J Stambrook, and J J Trill, and A C Smith, and C E Ogburn, and G M Martin
March 1998, Journal of cellular biochemistry,
Copied contents to your clipboard!